Thank you for donating!

You can donate using the following services.

Need support today?

Main menu

News

  1. 14.04.21

    Cyclo Therapeutics Inc: Update (13/4/21)

    Read more

  2. 25.03.21

    Cyclo Therapeutics Meets Primary Efficacy Endpoint in Phase 1/2 Trial from Intravenous Trappsol® Cyclo™ in Rare Disease Niemann-Pick Type C1 (NPC1)

    Read more

  3. 16.03.21

    University College London begins preclinical studies to develop a treatment for Niemann Pick C disease with support from the Columbus Foundation

    Read more

  4. 12.03.21

    Cyclo Therapeutics to Participate in Inaugural Emerging Growth Virtual Conference

    Read more

  5. 10.03.21

    Cyclo Therapeutics Appoints Russ Belden as Acting Chief Commercial Officer

    We are pleased to share the following update from Cyclo Therapeutics entitled 'Cyclo Therapeutics Appoints Russ Belden as Acting Chief Commercial Officer'...

    Read more

2023 Niemann-Pick UK (NPUK). Registered Charity: England and Wales (1144406) / Scotland (SCO45407). Registered as a company limited by guarantee in England and Wales (07775835).

Donate today